CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
The α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study
Authors
A Olincy
Ahmed A Othman
+35 more
CG AhnAllen
CR Bowie
CS Myers
D Kontis
D Umbricht
Deli Wang
E Granholm
ED Levin
G Simpson
George Haig
George M. Haig
J de Leon
JA Lieberman
JG Harris
Jun Zhao
K Posner
K Rickels
KH Nuechterlein
LD Alphs
M Dold
MF Green
N Andersen
O Agid
R Freedman
R Freedman
RC Smith
RS Keefe
RS Keefe
RS Keefe
RS Kern
RW Buchanan
RW Buchanan
S Kay
T Barnes
ZZ Guan
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1038%2Fnpp.2016.10...
Last time updated on 03/12/2019